KD

Kevin Dai

Managing Director at Vivo Capital

San Francisco Bay Area

Overview 

Kevin Dai is the Managing Director at Vivo Capital, with a background in clinical pharmacy, oncology, and integrative oncology. He has previously worked at prestigious institutions such as Memorial Sloan-Kettering Cancer Center and Merck, bringing a wealth of experience in clinical pharmacology and healthcare. Dai's career highlights include his role as a Clinical Oncology Pharmacy Specialist at Memorial Sloan-Kettering Cancer Center and his current position as Managing Director at Vivo Capital, where he focuses on investing in medical devices, pharmaceuticals, and biotechnology companies in the San Francisco Bay Area.

Work Experience 

  • Managing Director

    2015 - Current

Vivo is a global investment firm focused on healthcare with approximately $5.8 billion in AUM

  • Equity Research Associate - Healthcare/Biotechnology

    2014 - 2015

Canaccord Genuity is the global capital markets division of it, offering institutional and corporate clients idea-driven investment banking.

  • Clinical Oncology Pharmacy Specialist - Hematology/Oncology

    2011 - 2014

  • Research Intern - Biochemistry

    2006 - 2007

Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.

Raised $5,586,000.00 from Private Capital Advisors.

Articles About Kevin

Relevant Websites